BioMarin to Participate in 2019 RBC Capital Markets Global Healthcare Conference on May 21 in New York City
May 16 2019 - 08:30AM
PR Newswire (US)
SAN RAFAEL, Calif.,
May 16, 2019 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today
announced that Robert Baffi, Ph.D.,
Executive Vice President, Technical Operations, will participate in
a gene therapy manufacturing focused fireside chat at the RBC
Capital Markets Global Healthcare Conference on May 21 at 8:00am ET
in New York City. To access the live webcast, please visit the
investor section of the BioMarin website, www.biomarin.com. A
replay will also be archived on the site for at least one week
following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for patients with serious and
life-threatening rare and ultra-rare genetic diseases. The
Company's portfolio consists of several commercial products and
multiple clinical and pre-clinical product candidates for the
treatment of various diseases. For additional information, please
visit www.biomarin.com.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-2019-rbc-capital-markets-global-healthcare-conference-on-may-21-in-new-york-city-300851391.html
SOURCE BioMarin Pharmaceutical Inc.
Copyright 2019 PR Newswire
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Feb 2024 to Mar 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2023 to Mar 2024